Results 241 to 250 of about 249,070 (300)

SOCIETY NEWS

Brain Pathology, Volume 36, Issue 4, July 2026.
Audrey Rousseau
wiley   +1 more source

Social vulnerability shapes deep clinical phenotypes and brain health in aging and dementia across Latin America

Alzheimer's &Dementia, Volume 22, Issue 6, June 2026.
Abstract INTRODUCTION Adverse social conditions across the life course influence brain aging and dementia, yet their compounded impact on clinical phenotypes remains underexplored, particularly in Latin America, where social inequality and dementia burden are high.
Temitope Farombi, Tiago Azzi, Agustina Legaz, David Aguillón, José Alberto Avila‐Funes, Maria Isabel Behrens, Martín Bruno, Juan Felipe Cardona, Nilton Custodio, Carolina Delgado, Stefanie Pina‐Escudero, Maria del Pilar Garavito Galofre, Marcelo Maito, Nahuel Magrath‐Guimet, Justin B. Miller, Diana Matallana, Maira Okada de Oliveira, Guido Rocatti, Elisa de Paula França Resende, Andrea Slachevsky, Leonel Takada, Olivia Wen, Lina M. Zapata‐Restrepo, Brian Lawlor, Kristine Yaffe, Kun Hu, Bruce Miller, Katherine Possin, Jennifer S. Yokoyama, Sol Fittipaldi, Adolfo M. García, Hernan Hernandez Larzabal, Hernando Santamaria‐Garcia, Enzo Tagliazzuchi, Claudia Duran‐Aniotz, Agustin Ibanez, Joaquin Migeot   +36 more
wiley   +1 more source

Issue Information

Sustainable Food Proteins, Volume 4, Issue 3, September 2026.
wiley   +3 more sources

The include network: Advancing cross‐linguistic equity in brain health research

Alzheimer's &Dementia, Volume 22, Issue 6, June 2026.
Abstract Speech and language measures are increasingly recognized as sensitive, scalable, non‐invasive markers of diverse brain disorders. Yet, current research is overwhelmingly English‐centric, neglecting the world's vast linguistic diversity and undermining these markers’ global applicability.
Adolfo M. García, Jessica de Leon, Suvarna Alladi, Petronilla Battista, Agustina Birba, Stefano F. Cappa, Bárbara Costa Beber, Jessica Jiang, David Kemmerer, Maxime Montembeault, Juan Rafael Orozco‐Arroyave, Maria Luisa Gorno‐Tempini, Boon Lead Tee, the Include Network   +13 more
wiley   +1 more source

White matter hyperintensities are associated with locus coeruleus atrophy and astrocytic β2‐adrenergic receptor expression

Alzheimer's &Dementia, Volume 22, Issue 6, June 2026.
Abstract INTRODUCTION White matter hyperintensities (WMHs) are a robust marker of brain aging and dementia risk, typically attributed to vascular pathology. However, impaired astrocytic support may also contribute. The locus coeruleus (LC), which degenerates early in aging and Alzheimer's disease, provides widespread noradrenergic projections that ...
Victor Vidal, Gonzalo Farías, Carolina Delgado, Paul H. Delano, Rodrigo C. Vergara, Patricia Orellana, Tomás Ossandón, Nicolás A. Crossley, Cecilia Gonzalez‐Campo, Sharon L. Naismith, Raul Gonzalez‐Gomez, Carlos Coronel‐Oliveros, Agustín Ibáñez, Gabriel Wainstein, Robert D. Sanders, James M. Shine, Vicente Medel   +16 more
wiley   +1 more source

Fe de erratas [PDF]

Estado de Buenos Aires
core   +2 more sources

Beyond Vasospasm: Dual Milrinone and Balloon Angioplasty in Refractory Delayed Cerebral Ischemia Post‐Subarachnoid Hemorrhage

Clinical Case Reports, Volume 14, Issue 6, June 2026.
ABSTRACT Cerebral vasospasm is a major complication of aneurysmal subarachnoid hemorrhage and a key contributor to delayed cerebral ischemia, which remains a leading cause of morbidity despite standard therapy with nimodipine and induced hypertension.
Paul Cardozo Gil, Willy Pozo Soto, Alejandro Sengoku Cadima, Pablo Flores, Jorge Botello Marin, Gustavo Averanga, Richy Hurtado Montaño, Nelson Montalvo Flores   +7 more
wiley   +1 more source

ILAE dietary treatments task force special report: Maternal ketogenic diet exposure in epilepsy pregnancy registries—A call to action

Epilepsia Open, Volume 11, Issue 3, Page 702-709, June 2026.
Abstract Ketogenic dietary therapies (KDTs) are increasingly used worldwide as a non‐pharmacological treatment for epilepsy, including among people of childbearing potential. In many cases, KDTs allow for the reduction of antiseizure medications (ASMs) and lower drug exposure during pregnancy.
Magnhild Kverneland, Valentina De Giorgis, Laura Healy, Kelly Faltersack, Tanya J. W. McDonald, Marisa Armeno, Mackenzie C. Cervenka, Anita Devlin   +7 more
wiley   +1 more source